MYRIAD GENETICS, INC. Financing Receivable, after Allowance for Credit Loss
MYRIAD GENETICS, INC. (MYGN) had Financing Receivable, after Allowance for Credit Loss of $23.00 million as of 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Balance Sheet › Assets
us-gaap:NotesReceivableNet · last filed 2014-08-13
- 2013-12-31: Financing Receivable, after Allowance for Credit Loss $23.00M.
- 2013-09-30: Financing Receivable, after Allowance for Credit Loss $22.33M.
- 2013-06-30: Financing Receivable, after Allowance for Credit Loss $21.67M.
- 2013-03-31: Financing Receivable, after Allowance for Credit Loss $21.00M.
| Period end | Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2013-12-31 | $23.00M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $22.33M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $21.67M 10-K · filed 2014-08-13 |
| 2013-03-31 | $21.00M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $20.33M 10-Q · filed 2013-02-06 |
| 2012-09-30 | $19.67M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $19.00M 10-K · filed 2013-08-14 |
| 2012-03-31 | $18.33M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $17.67M 10-Q · filed 2012-02-01 |
| 2011-09-30 | $17.00M 10-Q · filed 2011-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |